Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Neuropharmacology
|
June 2, 2019
Brain insulin action: Implications for the treatment of schizophrenia
Sri Mahavir Agarwal, Chantel Kowalchuk, Laura Castellani, et al.
Schizophrenia Research
|
February 17, 2015
Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia
Shinichiro Nakajima, Hiroyoshi Takeuchi, Eric Plitman, et al.
Psychopharmacology
|
February 19, 2013
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study
Takefumi Suzuki, Ariel Graff-Guerrero, Hiroyuki Uchida, et al.
Journal of Gambling Studies
|
June 25, 2021
A Measure to Assess Illness Awareness in Problem Gambling: Gambling Awareness and Insight Scale (GAS)
Julia Kim, Aron Amaev, Lena C Quilty, et al.
Drug and Alcohol Dependence
|
August 2, 2021
A measure of illness awareness in alcohol use disorder-Alcohol Use Awareness and Insight Scale (AAS)
Julia Kim, Anmol Taggar, Lena C Quilty, et al.
Plos One
|
November 17, 2021
Individual determinants of COVID-19 vaccine hesitancy
Philip Gerretsen, Julia Kim, Fernando Caravaggio, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 11, 2015
Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study
Shinichiro Nakajima, Fernando Caravaggio, Isabelle Boileau, et al.
Psychiatry Research
|
July 18, 2018
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
Parita Shah, Yusuke Iwata, Eric Plitman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 28, 2018
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of <sup>1</sup>H-MRS studies
Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 3, 2018
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data
Miracle Ozzoude, Shinichiro Nakajima, Eric Plitman, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Neuropharmacology
|
June 2, 2019
Brain insulin action: Implications for the treatment of schizophrenia
Sri Mahavir Agarwal, Chantel Kowalchuk, Laura Castellani, et al.
Schizophrenia Research
|
February 17, 2015
Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia
Shinichiro Nakajima, Hiroyoshi Takeuchi, Eric Plitman, et al.
Psychopharmacology
|
February 19, 2013
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study
Takefumi Suzuki, Ariel Graff-Guerrero, Hiroyuki Uchida, et al.
Journal of Gambling Studies
|
June 25, 2021
A Measure to Assess Illness Awareness in Problem Gambling: Gambling Awareness and Insight Scale (GAS)
Julia Kim, Aron Amaev, Lena C Quilty, et al.
Drug and Alcohol Dependence
|
August 2, 2021
A measure of illness awareness in alcohol use disorder-Alcohol Use Awareness and Insight Scale (AAS)
Julia Kim, Anmol Taggar, Lena C Quilty, et al.
Plos One
|
November 17, 2021
Individual determinants of COVID-19 vaccine hesitancy
Philip Gerretsen, Julia Kim, Fernando Caravaggio, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 11, 2015
Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study
Shinichiro Nakajima, Fernando Caravaggio, Isabelle Boileau, et al.
Psychiatry Research
|
July 18, 2018
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
Parita Shah, Yusuke Iwata, Eric Plitman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 28, 2018
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of <sup>1</sup>H-MRS studies
Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 3, 2018
The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data
Miracle Ozzoude, Shinichiro Nakajima, Eric Plitman, et al.
Page
of 9